Is the use of linear low-dose extrapolation still justified for carcinogens?

Regulatory Toxicology and Pharmacology

Volumn 28, Issue 1, 1998, Pages 69-70

  Clayson, D B ^a  

^a NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYLATED HYDROXYANISOLE; CARCINOGEN; LIMONENE; N (2 FLUORENYL)ACETAMIDE;

ANIMAL EXPERIMENT; CARCINOGEN TESTING; CARCINOGENICITY; CHEMICAL CARCINOGENESIS; CHEMICAL MUTAGENESIS; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GENOTOXICITY; MALE; MOUSE; NONHUMAN; NOTE; ONCOGENE; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; RODENT CONTROL; TUMOR PROMOTION; TUMOR SUPPRESSOR GENE;

EID: 0031785049     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1006/rtph.1998.1240     Document Type: Editorial

References (7)

1. D.B. Clayson F. Iverson E.A. Nera E. Lok The importance of cellular proliferation induced by BHA and BHT Antioxidants: Chemical, Physiological, Nutritional and Toxicological Aspects 1992 Princetown Scientific Princetown p. 231–242
2. S.M. Cohen I.B. Ellwein Genetic errors, cell proliferation and carcinogenesis Cancer Res. 51 1991 6493 6505
3. E.R. Fearon R. Vogelstein A genetic model for colorectal tumorigenesis Cell 61 1990 759 767
4. W.G. Flamm L.D. Lehmann-McKeeman The human relevance of the renal tumor-inducing potential of d Regul. Toxicol. Pharmacol. 13 1991 70 86
5. A.G. Knudson Mutation and cancer: Statistical study of retinoblastoma Proc. Natl. Acad. Sci. USA 68 1971 820 823
6. 01 1979 Pathotox Park Forest South
7. United States Food and Drug Act, 1958, September 5